These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 27741306)

  • 21. Higher serum triglyceride to high-density lipoprotein cholesterol ratio was associated with increased cardiovascular mortality in female patients on peritoneal dialysis.
    Wu H; Xiong L; Xu Q; Wu J; Huang R; Guo Q; Mao H; Yu X; Yang X
    Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):749-55. PubMed ID: 26084271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation of reduction in urinary albumin excretion to ten-year cardiovascular mortality in patients with type 2 diabetes and systemic hypertension.
    Estacio RO; Dale RA; Schrier R; Krantz MJ
    Am J Cardiol; 2012 Jun; 109(12):1743-8. PubMed ID: 22440125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A difference in systolic blood pressure between arms is a novel predictor of the development and progression of diabetic nephropathy in patients with type 2 diabetes.
    Okada H; Fukui M; Tanaka M; Matsumoto S; Iwase H; Kobayashi K; Asano M; Yamazaki M; Hasegawa G; Nakamura N
    Atherosclerosis; 2013 Oct; 230(2):198-201. PubMed ID: 24075744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Level of physical activity associated with risk of cardiovascular diseases and mortality in patients with type-2 diabetes: report from the Swedish National Diabetes Register.
    Zethelius B; Gudbjörnsdottir S; Eliasson B; Eeg-Olofsson K; Cederholm J;
    Eur J Prev Cardiol; 2014 Feb; 21(2):244-51. PubMed ID: 24227183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal Function.
    Araki S; Haneda M; Koya D; Kondo K; Tanaka S; Arima H; Kume S; Nakazawa J; Chin-Kanasaki M; Ugi S; Kawai H; Araki H; Uzu T; Maegawa H
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2152-8. PubMed ID: 26563378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short sleep duration and type 2 diabetes enhance the risk of cardiovascular events in hypertensive patients.
    Eguchi K; Hoshide S; Ishikawa S; Shimada K; Kario K
    Diabetes Res Clin Pract; 2012 Dec; 98(3):518-23. PubMed ID: 23020940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study).
    Januszewicz A; Ritz E; Viberti G; Mimran A; Rabelink AJ; Rump LC; Ruilope LM; Katayama S; Ito S; Izzo JL; Haller H
    J Hum Hypertens; 2011 Nov; 25(11):679-85. PubMed ID: 21150933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated lipoprotein(a) levels predict cardiovascular disease in type 2 diabetes mellitus: a 10-year prospective cohort study.
    Lim TS; Yun JS; Cha SA; Song KH; Yoo KD; Ahn YB; Park YM; Ko SH
    Korean J Intern Med; 2016 Nov; 31(6):1110-1119. PubMed ID: 27756118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS).
    Sone H; Tanaka S; Tanaka S; Iimuro S; Oida K; Yamasaki Y; Oikawa S; Ishibashi S; Katayama S; Ohashi Y; Akanuma Y; Yamada N;
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3448-56. PubMed ID: 21865372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.
    Viana LV; Gross JL; Camargo JL; Zelmanovitz T; da Costa Rocha EP; Azevedo MJ
    J Diabetes Complications; 2012; 26(5):407-12. PubMed ID: 22677793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.
    Estacio RO; Coll JR; Tran ZV; Schrier RW
    Am J Hypertens; 2006 Dec; 19(12):1241-8. PubMed ID: 17161769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.
    Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
    Diabetes Obes Metab; 2018 Feb; 20(2):309-318. PubMed ID: 28722290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular autonomic neuropathy, erectile dysfunction and lower urinary tract symptoms in men with type 1 diabetes: findings from the DCCT/EDIC.
    Pop-Busui R; Hotaling J; Braffett BH; Cleary PA; Dunn RL; Martin CL; Jacobson AM; Wessells H; Sarma AV;
    J Urol; 2015 Jun; 193(6):2045-51. PubMed ID: 25584994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low triglyceride as a marker for increased risk of cardiovascular diseases in patients with long-term type 2 diabetes: A cross-sectional survey in China.
    Ren Y; Ren Q; Lu J; Guo X; Huo X; Ji L; Yang X
    Diabetes Metab Res Rev; 2018 Feb; 34(2):. PubMed ID: 29124871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Periodontal Treatment and the Risks of Cardiovascular Disease in Patients with Type 2 Diabetes: A Retrospective Cohort Study.
    Peng CH; Yang YS; Chan KC; Kornelius E; Chiou JY; Huang CN
    Intern Med; 2017; 56(9):1015-1021. PubMed ID: 28458305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.
    Astrup AS; Nielsen FS; Rossing P; Ali S; Kastrup J; Smidt UM; Parving HH
    J Hypertens; 2007 Dec; 25(12):2479-85. PubMed ID: 17984670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease in Individuals With Type 1 Diabetes: A 12-Year Follow-up Study.
    Hanssen NMJ; Scheijen JLJM; Jorsal A; Parving HH; Tarnow L; Rossing P; Stehouwer CDA; Schalkwijk CG
    Diabetes; 2017 Aug; 66(8):2278-2283. PubMed ID: 28588100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Night time blood pressure variability is a strong predictor for cardiovascular events in patients with type 2 diabetes.
    Eguchi K; Ishikawa J; Hoshide S; Pickering TG; Schwartz JE; Shimada K; Kario K
    Am J Hypertens; 2009 Jan; 22(1):46-51. PubMed ID: 18833198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progression of cardiovascular autonomic dysfunction in patients with type 2 diabetes: a 7-year follow-up study.
    Ko SH; Park SA; Cho JH; Song KH; Yoon KH; Cha BY; Son HY; Yoo KD; Moon KW; Park YM; Ahn YB
    Diabetes Care; 2008 Sep; 31(9):1832-6. PubMed ID: 18509202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.
    Theilade S; Hansen TW; Goetze JP; Rossing P
    Am J Hypertens; 2015 Jun; 28(6):772-9. PubMed ID: 25468806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.